KAIST Develops CRISPR-Based System for Precise RNA Modification in Living Cells
KAIST researchers developed a precise RNA modification technology using CRISPR-Cas13 and a hyperactive NAT10 variant, enabling targeted acetylation of specific RNAs in living cells and animals, which could advance RNA-based therapies and gene regulation research.